MIRA INFORM REPORT

 

 

Report Date :

27.11.2012

 

IDENTIFICATION DETAILS

 

Name :

AGOG PHARMA LIMITED

 

 

Registered Office :

Plot No.33, Sector-II, The Vasai Taluka Industrial Co-Operative Estate Limited, Gauripada, Vasai (East), Thane-401208, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

20.12.1990

 

 

Com. Reg. No.:

11-059515

 

 

Capital Investment / Paid-up Capital :

Rs.31.500 Millions

 

 

CIN No.:

[Company Identification No.]

U24230MH1990PLC059515

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacture and Exporter of Tablets, Liquid Orals, Capsules and Dry Syrup formulation

 

 

No. of Employees :

Not Available

 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (33)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 220000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow But Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. The reserve of the company appears to insufficient. However, trade relations are reported to be fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office / Factory :

Plot No.33, Sector-II, The Vasai Taluka Industrial Co-Operative Estate Limited, Gauripada, Vasai (East), Thane-401208, Maharashtra, India

Tel. No.:

91-95250-2455801 / 2452714 / 2453525

Fax No.:

91-250-2452074

E-Mail :

agog@vsnl.net

agoganil@rediffmail.com

agogpharma@rediffmail.com

Website :

www.agogpharma.com

 

 

 

 

DIRECTORS

 

AS ON 29.09.2012

Name :

Mr. Aziz Abdulhamid Damani

Designation :

Managing Director

Address :

Plot No.41/42, Rashid Khamis Road, P. O Box No.23584, Kampala, Uganda-23584

Date of Birth/Age :

12.05.1939

Date of Appointment :

20.06.2005

DIN No.:

00326536

 

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230MH1990PLC059515

AGOG PHARMA LIMITED

Managing director

01/04/2010

20/06/2005

Active

NO

 

 

Name :

Ms. Shenaz Aziz Damani

Designation :

Whole Time Director

Address :

Plot No.41/42, Rashid Khamis Road, P. O Box No.23584, Kampala, Uganda-23584

Date of Birth/Age :

07.08.1955

Date of Appointment :

02.06.2006

DIN No.:

00326523

 

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230MH1990PLC059515

AGOG PHARMA LIMITED

Whole-time director

01/04/2010

02/06/2006

Active

NO

 

 

Name :

Mr. Anilkumar Anirudh Pandey

Designation :

Whole Time Director

Address :

603-B, Silver Presidency, Sector II, Charkop, Kandivali (West), Mumbai-400067, Maharashtra, India 

Date of Birth/Age :

29.08.1965

Date of Appointment :

30.09.2005

DIN No.:

00326828

 

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230MH1990PLC059515

AGOG PHARMA LIMITED

Whole-time director

28/03/2006

30/09/2005

Active

NO

2

U51397MH2007PTC169185

MEDLIVE PHARMA PRIVATE LIMITED

Director

26/03/2007

26/03/2007

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 29.09.2012

 

Names of Shareholders

No. of Shares

Aziz Abdulhamid Damani

2500000

Shenaz Aziz Damani

499970

Anilkumar Anirudh Pandey

150010

Meera Anilkumar Pandey

5

Anirudh Chandrapati Pandey

5

Kamla Anirudh Pandey

5

Anamika Anilkumar Pandey

5

TOTAL

3150000

 

AS ON 29.09.2012

 

Equity Shares Break Up

Percentage of Holding

Directors or relatives of Directors

100.00

TOTAL

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacture and Exporter of Tablets, Liquid Orals, Capsules and Dry Syrup formulation

 

 

Products :

ITC CODE

PRODUCTS

300490

Pharmaceutical Products

 

 

GENERAL INFORMATION

 

Customers :

·         Dr. Reddy’s Laboratories Limited

·         Themis Medicare Limited

·         Ferring Pharmaceutical Private Limited

·         Strides Arcolab Limited

·         Brihanmumbai Municipal Corporation

·         Gittoes Pharmaceuticals Limited

·         City Mega-Chem Limited

·         Sungold Pharmaceutical

·         Rock Chemists Limited

·         Life Serve Private Limited

 

 

No. of Employees :

Not Available

 

 

Bankers :

·         State Bank of India, Industrial Finance Branch, S V Road, Malad West, Mumbai-400064, Maharashtra, India

 

 

Facilities :

Secured Loan

 

Rs. In Millions

31.03.2012

Rs. In Millions

31.03.2011

Long Term Borrowings

 

 

Term Loans

 

 

From Banks

11.349

11.529

Short Term Borrowings

 

 

Loans repayable on demand

 

 

From Banks

23.904

14.404

 

 

 

TOTAL

35.253

25.933

 

 

 

Unsecured Loan

 

Rs. In Millions

31.03.2012

Rs. In Millions

31.03.2011

Short Term Borrowings

 

 

Loans and advance from related parties

13.893

13.893

 

 

 

TOTAL

13.893

13.893

 

NOTES

 

Long Term Borrowings

 

(I)      Details of terms of repayment for the other long term borrowings and security provided in respect of the secured other long term borrowings

(Rs. In Millions)

Particulars

Terms of repayment of security

31.03.2012

31.03.2011

Term loans from banks

 

 

 

State Bank of India

Repayment Terms : April 2012 to March 2013 Rs. 5.400 Millions

April 2013 to March 2014 Rs. 6.600  Millions

April 2014 to March 2015 Rs. 6.600 Millions

April 2015 to July 2015 Rs. 2.800 Millions

Rate of Interest Floating

Primary Security : Hypothecation of the assets created out of bank finance

Collateral Security : Hypothecation of entire plant and machinery and moulds and other movable assets of the company

11.349

11.529

Total – Term Loans from Banks

 

11.349

11.529

 

(II)    Details of long term borrowings guaranteed by the directors

(Rs. In Millions)

Particulars

31.03.2012

31.03.2011

Term Loans From Banks

11.349

11.529

 

Short Term Borrowings

 

(i)      Details for security short-term borrowings

(Rs. In Millions)

Particulars

Nature of security

31.03.2012

31.03.2011

Loans repayable on demand

 

 

 

From banks

 

 

 

State Banks of India

Primary Security : Hypothecation of entire stock of raw material S I P and finished goods, book debts and other current assets

 

Collateral Security : Extension of EM of Company’s Leaseholds land and Factory Premises at the registered office

 

Rate of Interest : Floating 

23.904

14.404

Total – From Banks

 

23.904

14.404

 

 

 

 

Loans and advances from related parties

 

 

 

Mr. Aziz Damani

Nil

13.893

13.893

Total - Loans and advances from related parties

 

13.893

13.893

 

(ii)    Details of short-term borrowings guaranteed by some of the directors

(Rs. In Millions)

Particulars

31.03.2012

31.03.2011

Loans repayable on demand from banks

23.904

14.404

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S K Shetty and Associates

Chartered Accountant

Address :

D-101, Galaxy Heights, Goregaon Link Road, Goregaon (West), Mumbai-400104, Maharashtra, India

Tel. No.:

91-22-28799325

Fax No.:

91-22-28799326

E-Mail :

sksa123@yahoo.com

sksa123@live.in 

PAN No.:

AALFS5141D

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

3150000

Equity Shares

Rs.10/- each

Rs. 31.500 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

3150000

Equity Shares

Rs.10/- each

Rs. 31.500 Millions

 

 

 

 

 

NOTES

 

(a)    Reconciliation of the number of shares and amount outstanding at the beginning and at the end of the reporting period:

 

Particulars

AS At 31 March, 2012

Equity shares with voting rights

Number of Shares

Amount in Millions

As at the begging of the year

3,150,000.00

31.500

As at the end of the year

3,150,000.00

31.500

 

(b)    Details of shares held by each shareholder holding more than 5% shares

 

Name of Shareholder

AS At 31 March, 2012

Number of Shares

% of Holding

Equity shares of Rs.10/- each

 

 

Damani Abdulhamid Aziz

2,500,000.00

79.36

Damani Aziz Shenaz

499,970.00

15.87

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

31.500

31.500

30.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

25.427

17.180

11.095

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

56.927

48.680

41.095

LOAN FUNDS

 

 

 

1] Secured Loans

35.253

25.933

11.415

2] Unsecured Loans

13.893

13.893

7.808

TOTAL BORROWING

49.146

39.826

19.223

DEFERRED TAX LIABILITIES

2.138

1.302

1.357

 

 

 

 

TOTAL

108.211

89.808

61.675

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

64.101

43.121

38.031

Capital work-in-progress

0.000

22.197

0.947

 

 

 

 

INVESTMENT

0.050

0.050

0.050

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

25.047

33.621

16.508

 

Sundry Debtors

125.831

64.061

66.755

 

Cash & Bank Balances

2.633

2.029

15.395

 

Other Current Assets

6.542

10.634

0.000

 

Loans & Advances

57.438

34.979

17.166

Total Current Assets

217.491

145.324

115.824

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

151.186

106.913

91.352

 

Other Current Liabilities

20.875

12.709

0.000

 

Provisions

1.370

1.262

1.825

Total Current Liabilities

173.431

120.884

93.177

Net Current Assets

44.060

24.440

22.647

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

108.211

89.808

61.675

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

379.835

274.250

277.906

 

 

Other Income

6.661

0.433

13.531

 

 

TOTAL                                     (A)

386.496

274.683

291.437

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost o Material Consumed

291.331

231.200

236.842

 

 

Employee benefits expense

12.268

9.765

0.000

 

 

Other expenses

47.666

29.007

0.000

 

 

Direct Expenses

0.000

0.000

27.799

 

 

Office Admn, Selling and Distribution expenses

0.000

0.000

11.020

 

 

Changes in Inventories of finished goods, work in progress and stock in trade

8.735

(11.401)

(3.566)

 

 

TOTAL                                     (B)

360.000

258.571

272.095

 

 

 

 

 

Less

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

26.496

16.112

19.342

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

6.330

2.047

1.824

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

20.166

14.065

17.518

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

8.166

5.035

4.815

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX (E-F)                 (G)

12.000

9.030

12.703

 

 

 

 

 

Less

TAX                                                                  (H)

3.753

2.944

2.244

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX (G-H)                  (I)

8.247

6.086

10.459

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

NA

NA

0.482

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

NA

NA

10.941

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

346.021

248.404

NA

 

 

Freight Included In The Above Export

14.545

0.310

NA

 

 

Insurance charges included in above export

0.400

0.000

NA

 

TOTAL EARNINGS

360.966

248.714

NA

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

47.349

26.681

NA

 

 

Capital Goods

0.737

0.000

NA

 

TOTAL IMPORTS

48.086

26.681

NA

 

 

 

 

 

 

Earnings Per Share (Rs.)

2.62

--

--

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

2.13

2.22

3.59

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

3.16

3.29

4.57

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

4.26

4.79

8.26

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.21

0.19

0.31

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

3.95

3.33

2.77

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.25

1.20

1.24

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

Yes

19]

Payments terms

No

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

NOTE

 

Registered office has been shifted from A-21, New Empire Industrial Estate, Kondivita Lane, J B Nagar, Andheri (East), Mumbai-400059, Maharashtra, India  to the present address w.e.f. 02.06.2006

 

 

FORM 8

 

Corporate identity number of the company

U24230MH1990PLC059515

Name of the company

AGOG PHARMA LIMITED

Address of the registered office or of the principal place of  business in India of the company

Plot No.33, Sector-II, The Vasai Taluka Industrial Co-Operative Estate Limited, Gauripada, Vasai (East), Thane-401208, Maharashtra, India

This form is for

Modification of charge

Charge identification number of the charge to be modified

10085418

Type of charge

·         Immovable property

Particular of charge holder

State Bank of India, Industrial Finance Branch, S V Road, Malad West, Mumbai-400064, Maharashtra, India

Nature of instrument creating charge

No instrument was executed. Charge created by equitable mortgage by way of deposit of title deeds by constructive delivery.

Date of instrument Creating the charge

14.02.2012

Amount secured by the charge

Rs. 94.600 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest

Not applicable

 

Terms of repayment

Not applicable

 

Margin

Not applicable

 

Extent and operation of the charge

Security created to cover the principal amount together with interest, fees, commission, costs, charges and expenses including the legal costs.

Short particulars of the property charged (Including location of the property)

Immovable property being Survey No.42, Hissa No.01, Plot No.33, Sector II, admeasuring 904 sq. mtrs., Village Bilalpada, Taluka Vasai, District Thane

Date of instrument modifying the charge

14.02.2012

Particulars of the present modification

Charge over immovable property is extended to secure the enhanced credit facilities aggregating Rs.94.600 Millions.

 

FIXED ASSETS

 

·         Leasehold Land

·         Computer

·         Factory Building

·         Plant and Machinery

·         Furniture and Fixtures

·         Office Equipments

·         Electricity Installation

·         Goodwill

·         Software 

 

 

WEBSITE DETAILS

 

PROFILE

 

Subject consists of a team of individuals with an  ' EAGERNESS ' to produce superior quality medicines through setting of goals and objectives, along with prompt delivery schedules. They seek continuous upgrading of quality, focusing on customer satisfaction and Health care requirements of society.

They at Agog realize the need to assist and co-operate with the rest of the pharma industry In providing our nation with a tomorrow which is healthier and stronger.

Subject is a professionally managed pharmaceutical company manufacturing Tablets, Liquid Orals, Capsules and Dry Syrup formulations, at Vasai, Dist. Thane, Mumbai, India. Since 1995, Agog pharma has recorded an excellent growth to reach its present status of a Quality company in the areas of Health care.

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.69

UK Pound

1

Rs.89.19

Euro

1

Rs.72.10

 

 

INFORMATION DETAILS

 

Report Prepared by :

DPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

4

--RESERVES

1~10

4

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

33

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.